Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376

New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376

FromFrankly Speaking About Family Medicine


New Benefits Give SGLT2 Inhibitors Their Turn to Shine - Frankly Speaking Ep 376

FromFrankly Speaking About Family Medicine

ratings:
Length:
8 minutes
Released:
Apr 15, 2024
Format:
Podcast episode

Description

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376
Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.
Episode resource links:
DM/HF:  Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254
Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660

Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato
Released:
Apr 15, 2024
Format:
Podcast episode

Titles in the series (100)

A weekly Podcast series covering newsworthy topics in primary care medicine.